Factors associated with hypertension remission after gastrectomy for gastric cancer patients

Table 1 Baseline characteristics of the remission group and the non-remission group

Characteristics	Remission (n = 108)	Non-remission (n = 101)	P value
Age (yr)	63.6 ± 8.7	67.4 ± 8.0	0.001b
Sex			0.420
Male	70 (64.8)	60 (59.4)
Female	38 (35.2)	41 (40.6)
Pre-operative BMI (kg/m2)	23.4 ± 3.0	23.3 ± 32.9	0.770
Pre-operative weight (kg)	63.1 ± 10.0	61.9 ± 10.1	0.366
Pre-operative albumin (g/L)	39.5 ± 5.9	39.4 ± 5.3	0.902
Pre-operative hemoglobin (g/L)	117.9 ± 28.5	118.3 ± 24.4	0.922
Weight loss (kg)	-8.2 ± 6.7	-5.6 ± 4.6	0.001b
Smoking	39 (36.1)	41 (40.6)	0.923
Drinking	44 (40.7)	31 (30.7)	0.130
T2DM	21 (19.4)	19 (18.8)	0.908
CHD	9 (8.3)	20 (19.8)	0.017a
Hypertension classification			0.033a
I	27 (25.0)	25 (24.8)
II	51 (47.2)	32 (31.7)
III	30 (27.8)	44 (43.6)
Neoadjuvant chemotherapy	7 (6.5)	7 (6.9)	0.897
Surgical techniques			0.008b
Subtotal gastrectomy	74 (68.5)	85 (84.2)
Total gastrectomy	34 (31.5)	16 (15.8)
Reconstruction methods			0.771
B-I	37 (34.3)	36 (35.6)
B-II	15 (13.9)	17 (16.8)
R-Y	56 (51.8)	48 (47.6)
Tumor stage			0.174
I	37 (34.3)	36 (35.6)
II	15 (13.9)	17 (16.8)
III	56 (51.8)	48 (47.6)
Tumor size			0.556
< 5 cm	92 (85.2)	83 (82.2)
≥ 5 cm	16 (14.8)	18 (17.8)
Hypertension duration			0.346
≤ 5 yr	53 (49.1)	43 (42.6)
> 5 yr	55 (50.9)	58 (57.4)

^aP < 0.05.

^bP < 0.01.

Variables are expressed as the mean ± SD, n (%). T2DM: Type 2 diabetes mellitus; BMI: Body mass index; CHD: Coronary heart disease; B-I: Billroth I reconstruction; B-II: Billroth II reconstruction; R-Y: Roux-en-Y reconstruction.